Business
Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial Statements
TORONTO, CANADA / ACCESSWIRE / October 1, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PI...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial StatementsTORONTO, CANADA / ACCESSWIRE / October 1, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, is providing, as required by section 11(2)(a) of BC Instrument 51-517 - Temporary Exemption from Certain Corporate Finance Requirements (\"BCI 51-517\"), a 30-day update on its previously-announced 45-day extension of the filing of its interim financial statements for its second quarter ending June 30, 2020.Previously, on August 31, 2020, Perimeter announced that it would be relying on a 45-day extension period until October 15, 2020 under BCI 51-517. The Company continues to work within this extension period to complete the Interim Documents and expects to file the Interim Documents before October 15, 2020. In the interim, members of the Company's management and other insiders will be subject to a trading black-out that reflects the principles in section 9 of National Policy 11-207 until the Financial Statements have been filed.As background, on May 20, 2020, the Canadian Securities Administrators issued a notice stating that securities regulators will be providing coordinated relief consisting of a 45-day extension for certain periodic filings required to be made during the period from June 2, 2020 to August 31, 2020, as a result of the COVID-19 pandemic. Accordingly, the British Columbia Securities Commission has enacted BCI 51-517. Perimeter is relying on the temporary exemption pursuant to BCI 51-517 with respect to the requirement to file:i. quarterly financial statements for the period ended June 30, 2020 (the \"Financial Statements\") within 60 days after the end of the interim period as required by section 4.4(b) of National Instrument 51-102 - Continuous Disclosure Requirements (\"NI 51-102\");ii. management discussion and analysis for the periods covered in the Financial Statements (the \"MD&A\") within 60 days of the interim period as required by section 5.1(2) of NI 51-102; andiii. certifications of the Financial Statements (collectively with the Financial Statements and MD&A, the \"Interim Documents\") pursuant to section 5.1 of National ...